Navigation Links
Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D.
Date:1/24/2011

FRAZER, Pa., Jan. 24, 2011 /PRNewswire/ -- Cephalon, Inc., (Nasdaq: CEPH) will hold a public memorial service to celebrate the life of the company's founder and late Chairman and CEO on February 1, 2011, at 6:00 p.m. at The Franklin Institute, 222 North 20th Street, Philadelphia, Pennsylvania.

Dr. Baldino founded Cephalon in 1987 and led the company from a privately held startup to one of the top ten biotechnology companies in the world. He was a recognized pioneer in the biotechnology industry; but, his most enduring legacy will be his accomplishments as a civic leader, a mentor, a philanthropist, and most notably, a husband and father.

Dr. Baldino died on December 16, 2010, from complications associated with leukemia. He was 57 years old.

Visit http://www.cephalon.com/frankbaldinojr/ to view Dr. Baldino's obituary, donate to a cause in his honor, view additional details about the memorial service, and pay tribute to him on an online memorial.  

About Cephalon, Inc.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com/Media contacts:Fritz BittenbenderVice President, Public AffairsT: 610-883-5855Fbittenb@cephalon.comNatalie de VaneSr.  Director, Corporate Communications & Public AffairsT: 610-727-6536C: 484-319-3722ndevane@cephalon.com
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.
2. Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely
3. Cephalon Reports Record Earnings and Raises 2010 Guidance
4. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
5. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
6. Cephalon Completes Acquisition of Arana Therapeutics
7. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
8. Cephalon Quarterly Conference Call Invitation
9. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
10. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... ... 09, 2017 , ... The award-winning American Farmer television series will feature 3 ... airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten ... to continue to feed a growing nation. At the same time, many of our ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... and applications consulting for microscopy and surface analysis, Nanoscience Instruments is now ... Analytical offers a broad range of contract analysis services for advanced applications. ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
Breaking Biology News(10 mins):